An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.
Clinical trial NCT02598960 · COMPLETED
Trial details
- NCT number
- NCT02598960
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-14
- Primary completion
- 2019-12-16
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.